Down Syndrome risk of Alzheimer’s connected to white matter integrity

Brain scans of 10 persons with Down syndrome but no dementia, 10 persons with Down syndrome and dementia, and 10 healthy controls, have revealed a linear correlation between cognitive ability and compromised white matter connections in the frontal lobes among those with Down syndrome. Those with higher cognitive ability and motor skill coordination had healthier white matter integrity, and those with additional dementia showed the most deterioration.

Adults with Down Syndrome are known to be at high risk of developing Alzheimer’s after age 40.

http://www.eurekalert.org/pub_releases/2014-04/uok-nrs040714.php

[3600] Powell, D., Caban-Holt A., Jicha G., Robertson W., Davis R., Gold B. T., et al.
(2014).  Frontal white matter integrity in adults with Down syndrome with and without dementia.
Neurobiology of Aging. 35(7), 1562 - 1569.

Related News

Analysis of data from 418 older adults (70+) has found that carriers of the ‘Alzheimer’s gene’, APOEe4, were 58% more likely to develop mild cognitive impairment compared to non-carriers.

New findings support a mathematical model predicting that the slow, steady firing of neurons in the d

In a large Mayo Clinic study, self-reported diet was found to be significantly associated with the risk of seniors developing mild cognitive impairment or dementia over a four-year period.

The olfactory bulb is in the oldest part of our brain. It connects directly to the

Dietary changes affect levels of biomarkers associated with Alzheimer's

In a study in which 78 healthy elders were given 5 different tests and then tested for cognitive performance 18 months later, two tests combined to correctly predict nearly 80% of those who developed significant cognitive decline.

A small study suggests that the apathy shown by many Alzheimer's patients may not simply be due to memory or language problems, but to a decreased ability to experience emotions.

By following 597 Alzheimer’s patients over 15 years, researchers have determined that a simple progression rate can be calculated at the initial visit, using symptom onset and present performance, and that this can reliably identify slow, intermediate and rapid progression.

A preliminary study suggests that a regime of high doses of folic acid, B12 and B6 reduces levels of homocysteine in people with mild to moderate Alzheimer’s.

A chemical called methionine (an amino acid found in beta-amyloid) may be the source of the toxic free radicals produced by the amyloid-beta peptide.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news